The authors found concurrent growth in pharmacy benefit manager market concentration and worsening of patient access measures across states from 2016 to 2025.
|Articles|August 1, 1999
Supplements and Featured Publications
- Clinical Management of Respiratory Infections: Healthcare Decisions in an Age of Increasing Pathoge
- Volume 5
- Issue 11 Suppl
Emergence of Antibiotic Resistance in Upper and Lower Respiratory Tract Infections
Author(s)Michael R. Jacobs, MB, BCh, PhD
Advertisement
Articles in this issue
over 27 years ago
Participating Facultyover 27 years ago
Introductionover 27 years ago
Challenges in the Management of Otitis Mediaover 27 years ago
Difficulties in the Diagnosis and Treatment of Sinusitisover 27 years ago
Selected Abstractsover 27 years ago
BibliographyAdvertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
Real-World Cohort Ties JAK Inhibitors in Alopecia Areata to Menstrual Side Effects
2
Phase 3 Trial Tests Ensifentrine for COPD Exacerbation Prevention
3
Tarlatamab Plus Durvalumab Cuts Risk of Death by 58% as First-Line Maintenance in ES-SCLC
4
Trends in Pharmacy Benefit Manager Market Dynamics, 2016-2025
5